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   The lipolytic activity of the isolated lung perfusion fluid and lung tissue 
was demonstrated and also the activity of whole animal plasma was measu-
red. After perfusion, the lipid composition of both lung tissue and fatty 
acid composition of phospholipid subfraction were investigated. The activity 
of lung tissue was reduced after perfusion. From force fed dogs, the lipol-
ytic activity of perfusion fluid and lung tissue was higher than that from 
fasted dogs. The dog lung injected with fibrin clots showed a reduction of 
the lipolytic activity and the simultaneously collected plasma lipolytic acti-
vity was decreased in comparison with that of normal dogs. It was proved 
that the dextran infused dog lung had lipolytic activity and these substances 
had a heparinlike action. Furthern ore, free fatty acid was produced into 
the perfusion fluid. On the otherhand, the analysis of lung lipid contents, 
phospholipid fraction was reduced following the reduction of the rate of 
choline in the dextran infused lungs. 
   In the fatty acid composition of choline in the postperfusion lung tissue 
from dextran infused dogs, the amount of palmitic acid was decreased. 
These findings suggest that the lung perform an active lipid metabolism 
and the lipoprotein lipase may be situated in the capillary bed surface. The 
results from the analysis of lipid composition of lung tissue in this study 
may be related to the surface active agents.
                  INTRODUCTION 
   Since HAHN" had discovered in 1943 that the alimentary lipemia 
was cleared rapidly in dogs by the intravenous injection of heparin, 
many studied' 31 , 4) , 51 on the clearing factor were performed. ANDERSON 
and FAwcett6' and BROWN, BOYLE and ANFINSEN" demonstrated the 
appearance of a lipolytic enzyme in the blood after the injection of 
heparin in vivo and in vitro, which hydrolysed artificial triglyceride 
emulsion. This enzyme differed from pancreatic lipase from the studies 
on various activators and inhibitors and was named clearing factor 
lipase. On the otherhand, KORN8 , 91 had demonstrated the same lipolytic 
enzyme in the tissue and named it lipoprotein lipase, because the 
enzyme hydrolysed only the protein bounded triglyceride or chylomic-
ron. This enzyme is not present in normal blood but appears in the
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absorption of lipids. 
   In spite of many efforts., this enzyme has not been obtained in 
pure form. On the perfusion studies of hearts 10' or limbs 11' using the 
fluid containing heparin and plasma albumin, the clearing factor was 
released rapidly in the perfusion fluid and these results have supported 
that the enzyme localized on the vascular wall might be easily liberated 
into the blood stream by combinding with heparin. This enzyme cata-
lyses . the hydrolysis of the triglyceride moiety of chylomicrons and low 
densitiy 8-lipoproteins. After the tissue lipoprotein lipase was first de-
termined in the rat hearts by KORN"," in . the extracts of adipose tissue 
12),13),14),15) , mammary gland 16), lung "11,1" and arterial blood vessel 
wall", the same enzyme was demonstrated. In vivo, orally administra-
ted exogenous fats are absorbed by the intestine and carried to the lung 
through the thoracic duct. The lung is the first important organ to be 
reached by the fats and this anatomical characteristic suggests that 
the lung may play an important role in lipid metabolism. There is a 
report that the lung has the function of taking up the circulating 
triglycerides and hydrolyses. LOCHNER19> reported that the lung released 
free fatty acid, because the free fatty acid level was higher in the 
arterial blood than simultaneously drawned mixed venous blood in man 
and dog. 
   SCHRADE20) reported that the lung had the ability of uptake of lipid 
in rats after oral administration of olive oil. Also it is clinically reco-
gnized that pulmonary tuberculosis is often accompanied by a fatty 
liver and pneumonia 211,221 . Lung cancer and tuberculosis cause lipemia 
23) , 24) , 25) , 26) . In the present study, for the exclusion of the influence of 
other organs, especially of the liver, the isolated dog lung was perfused 
and the lipolytic activity of perfusion fluid, lung tissue and also plasma 
of whole animal was measured. The lipid composition of postper-
fused lung tissue was compared with unperfused lung tissue. Further-
more, the phospholipid subfraction and its fatty acid composition were 
analysed. 
       EXPERIMENTAL MATERIALS AND METHODS 
   (A) Treatment of Animals (Table 1) 
   Healthy mongrel dogs of both sexes maintained on a normal kennel 
diet and weighing between 7 to 12 Kg were used. The animals were 
divided into three groups. 
   Group 1. . Five animals were only fasted overnight before the expe-
riment and three other animals were fed forcibly 50 ml of ethyl-linoleate 
through a stomach tube under intravenous sodium pentobarbital anest-
hesia (30-60 mg when necessary) after fasting overnight. The latter 
animals were used six hours after ethyl-linoleate administration. This
     Table 1 
Distribution of Animal:
                                                 Number of animals 
         Group of Animals 
                                       Perfusion fluid Plasma Lung Tissue 
                      Fasted 5 3 3 
1. Intact 
                      Force Fed 3 3 3 
                      Fasted 3 3 3
2. Fibrin Clots 
      Injection Force Fed 5 3 3 
                      Fasted 3 3 3
3. Dextran 
       Infusion Force Fed 4 3 3
group was used for the control. 
   Group 2. In eight animals, pulmonary vascular lesions were prod-
uced by fibrin clots injection following the procedure of BARNARD27). 
Namely 20 ml of dog blood was collected aseptically and allowed to clot. 
The serum was discarded and the clots were homogenized and washed 
in sterile saline until they were buff to pink in color and suspended in 
20 ml of sterile saline. This clot suspension was injected intravenously 
four times at a week interval. In these animals, three were fasted 
and the other five were fed forcibly ethyl-linoleate six hours before 
the experiment. 
   Group 3. In seven animals, rapid intravenous infusion of dextran 
(6% dextran (high molecular weight) in 5% glucose solution) was per-
formed by the procedure of Said 281. Infusion rate was 30-40 ml per min-
ute.In each animal, 0,5 and 30 minutes after the beginning of infusion, 
5 ml of blood was collected and used for determination of lipoprotein 
lipase. In these animals, three were fasted, and the other four were 
fed forcibly ethyl-linoleate six hours before experiment. In group 2 
pulmonary vascular lesions and in group 3 lung edema were demonstr-
ated histologically. 
   (B) Perfusion Technique 
   The left lung of the experimental animals was isolated following the 
technique of WEST291. The animal was anesthetized with sodium pentobar-
bital and fixed on the operating table on the right lateral position. The 
thoracotomy was done via a left forth or fifth intercostal incision. After the 
pulmonary ligament was incised, the left pulmonary artery and the 
left bronchus were isolated and incised. Finally the left auricule was 
incised. The left lung was then removed and the pulmonary artery and 
left auricle were washed with 50 ml of 1/10M oxalated acid. Immediately
after washing, the glass cannula filled with perfusion fluids was tied 
into the left pulmonary artery and then the left bronchus was tied into 
the another glass cannula for respiration. Diagram of perfusion was 
shown in Fig. 1. This procedure was finished within five minutes after
Fig. 1 Diagram of Perfusion
the removal of the lung. Perfusion was carried out by T-N type micro-
perfusion pump made by NATUME Industry. Perfusion rate was 40 ml per 
minute. Respiration was established manually and the rate of respira-
tion was 16-20 per minute. The perfusion fluid consisted of 0.1 vol. of 
20% Fatgen, one vol. of dog oxalated plasma, one vol. of phosphate 
buffer (pH 8.0) and one vol. of 0.9% saline. 
   (C) Enzyme Sample 
   (1) Plasma. After drawing five ml of blood, sodium heparin (10u 
per Kg body weight) was injected into foreleg vein and 3,5,10,30 and 
60 minutes after the injection, each five ml of blood was drawn with 
1/10 vol. of 1/10 M oxalated acid and immediately chilled at 4°C in the 
ice box. Each sample was centrifuged for 10 minutes at 4,000 rpm in 
0°C and the supernatant layer was used as a specimen. 
   (2) Lung Tissue. Lung tissues from right and left lungs (in which the 
left lung was perfused) weighing exactly 500 mg were placed into the 
glass homogenizer added two ml of physiological saline solution. After 
homogenizing them in the ice bath, the homogenate was centrifuged 
for 10 minutes at 4, 000 rpm in 0°C. One ml of each supernatant layer 
was obtained for the measurement of lipolytic activity. 
   (3) Perfusion Fluid. The fluid was used as an enzyme sample,
   (D) Assay of Lipolytic Activity30 
   The substrate contained 0.1 vol. of 20% Fatgen (sesame oil emul-
sion),one vol. of dog oxalated plasma (heated at 56°C for five minutes 
and filtrated), one vol. of phosphate buffer (pH 8.0), and one vol. of 
0.9% saline. The substrate was preincubated at 37°C for 30 minutes 
before use. Immediately after mixing one ml of the sample of lung 
tissue or plasma was placed into 1.5 ml of the substrate, one ml of the 
mixture was placed into DOLE' S31) extraction mixture and the rema-
ining mixture was incubated at 38°C for 30 minutes. One ml of the per-
fusion fluid was immediately added into D3LE's311 extraction mix-
ture and the remaining fluid was incubated at 38°C for 30 minutes. 
One ml of each incubated mixture was also placed into DOLE 7 s31) 
mixture. Measurement of free fatty acid was followed by DOLE'S meth-
od . 31' One ml of the sample was added into the glass stoppered tube 
with five ml of DOLE's 31) extraction mixture (40 parts by volume of 
isopropyl alcohol, 10 parts heptane, and one part 1 N H2SO4) and sha-
ken vigorously for 10 minutes. After standing 10 minutes, 3 ml of 
heptane and two ml of water (CO2 free) were introduced into the mix-
ture, and then shaken vigorously for five minutes. Three ml of the 
upper heptane layer was transferred into a conical centrifugal tube con-
taining one ml of DoLE's313 titration mixture (0.01% thymol blue and 
90% ethanol in water) and then titrated with 0.018 N sodium hydroxide 
using a microburette. A stream of nitrogen was delivered to the bottom 
of the test tube and forced carbon dioxide from the sample. In all the 
experiments, palmitic acid standard and the heptane layer adding no 
sample as a blank were similarly titrated. A lipolytic activity was re-
presented as the differences of free fatty acid concentration in the mix-
ture before and after incubation. The nitrogen content of lung tissue 
homogenates were also measured by Micro-Kjeldahl method. 
   (E) Extraction of Lipid 
   Lipids from lung tissue were extracted by the method of Folch and 
LEES32) . Total lipid was measured by the gravimetry. Triglyceride was 
measured by the method Of VAN-HANDEL and ZILVERSMIT33) , phospholipid 
by the method of ALLEN341 , and total cholesterol by the method of ZAx35> 
and HENLY36). Analysis of phospholipid subfractions were accomplished 
by the modified microquantitative method of KATES37. 
   (F) Gas Liquid Chromatography 
   Separation of the extracted lipids into simple lipid and phospholipid 
was performed by thin layer chromatography. Methylesterification of 
fatty acid was done by STOFFEL'S 38) method. Analytical condition of 
gas liquid chromatography is shown in Table 2. The identification of 
each fatty acid was performed by the retention time39' . Quantity of 
each fatty acid was calculated by the weight of curves, and expressed 
as percentage of the total weight.
                 Table 2 
Analytical Condition of Gas Liquid Chromatography 
Appa, atus SHIMADZU GC-IB 
Colum Diethylenglycol Succinate 15% on Shimaleite 
       Support mesh 60-80 
I.D. 4 mm Length 3 m 
Column Temperature 200°C 
Sample Temperature 280-C 
Detector Temperature 240°C 
Carrier Gas He Flow Rate 30 ml/min. Pressure 3.0kg/cm2 
Detector Hydrogen Flame Ionization Detector (Type HFD-1) 
H2 Flow 70m1/min. Air Flow 700m1/min.
                     RESULTS 
   (A) Condition of the Perfusion 
     (a) Heparin Concentraton (Fig. 2-a). In the amounts of heparin 
added through the perfusion system, (varying 0.02-0.2m1) no change 
was seen on the activity of lipoprotein lipase released into the perfusion 
fluid and so in this study 0.2 ml of heparin was added to every exper-
iment.
                      Fig. 2 Condition of Perfusion 
(a) Effect of the amount of Heparin (b) Effect of Perfusion Rate
     (b) Perfusion Rate (Fig. 2-b). In comparison with the perfusion 
rate between 20 and 40 ml per minute, no marked difference was seen 
in the activity of lipoprotein lipase. In this experiment, the perfusion 
rate was performed in 40 ml per minute. 
   (B) Lipolytic Activity of Perfusion Fluid from the Normal Dogs
Fie. 3 Linolvtic Activity of the Perfusion Fluid (Group 1)
      (Group 1) 
     (a) Dogs Fasted for 24 Hours (Fig. 3). Five minutes after starting 
the perfusion, heparin was introduced through the perfusion system. 
The lipolytic activity increased rapidly, and was maximum in three 
minutes after the introduction of heparin, and fell off rapidly. 30 mi-
nutes after adding heparin, the activity was similar to the level before 
the heparin was introduced. 
     (b) Force Fed Dogs (Fig. 3). The same experiment was carried 
out six hours after the administration of ethyl-linoleate. The lipolytic 
activity was present before adding heparin. After adding heparin, the 
activity markedly increased and reached a maximum in three minutes 
after the starting of perfusion. Its maximum rate was 1.6 times higher 
than in fasted animals and then stayed at a plateau level. This figure 
differed significantly from that of the fasting dogs. 
   (C) Lipolytic Activity of Lung Tissue in Intact Dogs (Fig. 4) 
      (Group 1) 
    (a) Dogs Fasted for 24 Hours. Lipolytic activity in the left lung ti-
ssue (used in the perfusion study) was lower than that in the unper-
fused right lung tissue. 
    (b) Force Fed Dogs. Lipolytic activity in the right lung tissue 
was significantly higher than that in the fasted animals, but in the 
left tissue lipolytic activity was markedly decreased. This decrease of 
lipolytic activity suggested that lipoprotein lipase was released into the 
perfusion fluids. 
   (D) Plasma Lipolytic Activity in Vivo of the Control Dogs (Fig. 5)
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               Fig. 4 Lipolytic Activity of the Lung Tissue 
R: Right Lung L: Left Lung (1) fasted (2) force fed (3) clots-fasted 
                           (4) clots-force fed (5) dextran-fasted
                            (6) dextran-force fed 
Values expressed as Mol/100 mg Nitrogen/30 min. 
                Fig. 5 Plasma Lipolytic Activity (Group 1)
   Intravenous injection of heparin caused the increase of lipolytic 
activity in plasma. In the fasted state, maximum rate was present five 
minutes after the injection of heparin, and the activity was significan-
tly decreased 60 minutes after. On the contrary, in force fed animals 
the maximum value was higher than that in fasted animals and was 
present 60 minutes after the injection. The increased lipolytic activity 
might be due to the administration of ethyl-linoleate. 
   (E) Alteration of Lipolytic Activity in Lung of Fibrin Clots Injected Dogs 
      (Group 2) 
    (a) Lipolytic Activity of Perfusion Fluids (Fig. 6). In the fasted 
animals, the lipolytic activity was elevated but the maximum value 
was present in five minutes after adding heparin and this elevation 
was differed from that of intact animals. In force fed animals, the
Fig. 6 Lipolytic Activity of the Perfusion Fluid (Group 2)
increasing rate of the activity was not so high as that in intact force 
fed animals. This fact may be due to the effects of the alteration of 
the lung capillary beds. 
    (b) Lipolytic Activity of Lung Tissue (Fig. 4). The lipolytic acti-
vities of the right lung (unperfused) and the left lung (perfused) were 
higher in force-fed dogs than in fasted dogs but in both the activities 
were reduced in comparison with the intact one. After perfusion, the 
activities of both the lungs were reduced and the marked reduction of 
the activity was seen in force fed dogs. This reduction of the activity 
might be due to release of lipolytic enzyme into perfusion fluid. 
    (c) Plasma Lipolytic Activity (Fig. 7). The lipolytic activity of 
the fasted dog plasma became maximum between five to ten minutes
Fig. 7 Plasma Lipolytic Activity (Group 2)
after the injection of heparin, and decreased about a half of maximum 
value in 20 minutes after the injection in comparison with intact force 
fed dogs. The disappearance of the activity was retarded and maximum 
value was about two thirds of the intact dogs. 
   (F) Release of Lipoprotein Lipase in Dextran Infused Dogs (Group 3) 
    (a) The Lipolytic Activity of Perfusion Fluids (Fig. 8). The lipo-
lytic activity of perfusion fluid was present before heparin was intro-
duced, thus differing from them in group 1 and 2. Five minutes after 
adding heparin into the perfusion fluid, the activity increased signifi-
cantly and the maximum value was highest in three groups. In 60 mi-
nutes after the starting of perfusion, the activity remained. The effect 
of ethyl-linoleate was also observed. 
    (b) Lipolytic Activity of Lung Tissue (Fig. 4) In the right lung 
from fasted dogs, the lipolytic activity was about equal to that of nor-
mal healthy force fed dogs. In the left lung, the activity of force fed 
and fasted dogs was decreased to about half of the right lung. 
    (c) Plasma Lipolytic Activity (Fig. 9) After the starting of dextran 
infusion, the lipolytic activity of plasma was observed on the interval 
of 10 minutes till 60 minutes, because dextran (high molecular weight) 
itself has the heparinlike effect and the action of release of lipoprotein 
lipase. The maximum level was about 1/10 times lower than that of 
normal dogs. 60 minutes after the perfusion, the activity disappeared. 
The effect of ethyl-linoleate was not seen. This may be caused by dilu-
tion of plasma from dextran infusion. 
   (G) Free Fatty Acid Production from the Lung 
   After the starting of the perfusion, free fatty acid contents increa-
Fig. 8 Lipolytic Activity of the Perfusion Fluid (Group 3)
Fig. 9 Plasma Lipolytic Activity (Group 3)
sed in all three groups. In the lungs of force fed intact animals, the 
production of free fatty acids was somewhat elevated (Fig. 10). In 
animals injected with clots, free fatty acid production was not so high 
as that of normal animals (Fig. 11). In dextran infused animals, free
fatty acid production was markedly increased, and administration of 
ethyl-linoleate produced an increase of free fatty acid (Fig. 12).
Fig. 10 Free Fatty Acid Production through the Lung (Group 1)
Fig. 11 Free Fatty Acid Production through the Lung (Group 2)
Fig. 12 Free Fatty Acid Production through the Lung (Group 3)
                Table 3 
Lipid Composition of Right Lung (before Perfusion)
            Total Lipid Phospholipid Triglyceride Total Cholesterol 
 fasted 
Group 1 68.5± 3.2 41.1± 8.7 4.3±0.7 15.8±4.4 
Group 2 72.9±- 6.3 34.7± 1.8 2.9±1.0 21.9 
Group 3 37.5±-14.2 27.3±11.9 1.5 ±-0.8 7.4±4.7 
force fed 
Group 1 77.3± 6.1 56.4-+12.0 1.7±0.2 14.8±3.6 
Group 2 74.0± 5.2 43.2 6.1 2.1 ±-0.8 17.2±1.4 
Group 3 39.8 ±-11.1 28.5.±-9.6 1.3±0.4 11.5±3.9
           * mg/2.5 g of wet weight ** standard deviation 
   (H) Lipid Composition of Right Lung (Table 3) 
   In force fed dogs of group 1 and 2, especially in group 1, the am-
ount of total lipid increased and that of group 3 was markedly reduced.
In the amount of phospholipid of force fed animals, the marked increase 
was shown in group 1 and 2. The amount of total cholesterol increased 
in group 2. The triglyceride contents of force fed animals was reduced 
in group 1. The increase of the amount of total lipid in force fed an-
imals of group 1 was caused by the increase of phospholipid and the 
increase in group 2 was due to the increase of total cholesterol.
(I) Lipid Composition of Left Lung (Table 4) 
                     Table 4 
     Lipid Composition of Left Lung (after Perfusion)
            Total Lipid Paospholipid Triglyceride Total Cholesterol 
 fasted 
                   * ** 
Group 1 65.2± 5.6 43.6±4.8 3.9±1.2 17.1±4.5 
Group 2 63.8± 4.9 32.7±2.7 3.7±0.9 22.7±3.0 
Group 3 35.5- 6.4 23.6±7.2 1.1 6.2±0.9 
force fed 
Group 1 59.3±9.5 41.2±5.4 2.9±1.1 17.6±3.0 
Group 2 60.8±6.3 26.9±4.2 ~ 2.8±1.0 13.7±2.2 
Group 3 35.5±4.9 22.6±2.5 I 1.5±0.4 7.2±0.8
* mg/2 .5 g of wet weight ** standard deviation
   The amount of total lipid decreased in all groups except for the 
fasted animals of group 1. The decrease of the amount of phospholipid 
was observed in the force fed animals of the three groups. The amount 
of total cholesterol was reduced in the force fed animals of group 2 and 
3, in comparison with that of fasted animals. The amount of trigly 
ceride did not show any remarkable changes in each group 1 and 2. 
   (J) Pi oportiorz of Phospholipid Subfraction (Fig. 13) 
   By thin layer chromatographic technique, the lung phospholipid was 
separated into five subfractions, which were consisted of phosphatidyl-
choline, ethanolamine, sphyngomyelin, lysolecithin and an unidentified 
spot. More than 50 % of the amount of phospholipid was occupied 
by choline fraction. The decrease of the phospholipid contents in the 
force fed dogs extending from group 1 to 3, was revealed in the red-
uction of the choline or ethanolamine fraction. The other subfractions 
of phospholipid did not show any remarkable changes. 
   (K) Fatty Acid Composition of Choline 
   The results of group 1 (fasted dogs) and group 3 are shown in 
Fig. 14 (a) (b).
Fig. 13 Proportion of the Amount of Phospholipid Subfraction
   The concentration of the saturated fatty acid (16:0 and 18:0) dec-
reased and the unsaturated fatty acid (16:1, 18:1, 18:2, 18:3 and 20:4) 
increased in the right (unperfused) dextran infused dog lung. The rem-
arkable change was noted in the dextran infused force fed dog lungs 
(Fig. 14-a). The changes of the concentration of the saturated fatty 
acid in the left (perfused) dextran infused dog lung decreased similarly 
to the findings in the right lung (Fig. 14-b). 
                    DISCUSSION
   In this study, it was demonstrated that the normal dog lung had a li-
polytic activity. From force fed dogs, the lipolytic activity of perfusion 
fluids was higher than that of fasting dogs. The lipolytic activity of lung
Fig. 14 (a) Fatty Acid Composition of Choline (Right Lung Tissue)
Fig. 14 (b) Fatty Acid Composition of Choline (Left Lung Tissue)
tissue was decreased after perfusion and the decreasing rate was mar-
ked in the force fed postperfusion lung. Plasma lipolytic activity incr-
eased in the force fed animals. In 1943, HAHN" observed that heparin
caused rapid clearing of alimentary lipemic plasma in vivo but that 
this decrease in turbidity did not occur in vitro. It has been demons-
trated by many investigators that a lipolytic enzyme appeared in the 
blood rapidly after the injection of heparin, and the enzyme was found 
only in curde form. E.D. KORN8 demonstrated no lipolytic enzyme in 
lung aceton powder extracts. On the otherhand, it was demonstrated ., 
many years ago, from the work of HAMSIK and others40' that this tissue 
contained lipolytic enzymes. ZEMPLENYI and G-ZAFNETTER16) demonstrated 
the lipolytic activity of the lung from some species and SAILER et a1412 
reported similar results. HEINEMANN18) reported that the fresh tissue 
showed no change of lipolytic activity but the aceton extracted tissue 
had activity, and that the plasma lipolytic activity was not changed 
by perfusion through the lung. JEFFRIES42), however, observed in rats 
the appearance of lipolytic activity in the perfusion of heparin contain-
ing blood through the lung (and also in the isolated hind limb, the 
abdominal viscera, the skin and the subcutaneous tissue). In this 
study, the plasma lipolytic activity was higher in force fed animals 
than that in fasted animals. The lung tissue lipolytic activity increased 
in force fed animals and after perfusion, the activity decreased mar-
kedly. This fact suggested that the lipoprotein lipase localizing in the 
pulmonary capillary wall was released into the perfusion fludis, because 
the elevation of the lipolytic activity of the perfusion fluids continued 
until 60 minutes after the starting of the perfusion. Many studies 27), 
43),44),45),46),47) have been carried out in experimental pulmonary fibrosis 
or arteriosclerosis. In rabbits, the repeated intravenous injection of 
small fibrinous clots from human blood led to fibroelastic intimal thi-
ckenings of the pulmonary arterioles43). In another experiment in rab-
bits, the intravenous injection of minute fibrin emboli from rabbit's 
own blood caused an acute inflammatory arteritis, and also interstitial 
pneumonia. The fibrin clots were organized into the pulmonary arte-
rial wall and these findings were similar to the human primary pulmo-
nary arteriosclerosis, and not to atherosclerosis27) . In the clinical state, 
arteriosclerotic patients have ordinarily hyperlipemia supporting the 
relationship between arteriosclerosis and lipoprotein lipase activity. 
There is a report that the endogenous lipoprotein lipase activity in 
fasting human plasma was slightly reduced48). Another report proved 
that there was a difference between healthy and arteriosclerotic patients 
in the postheparin plasma lipoprotein lipase activity. It has also been 
noted that arteriosclerotic patients have an inhibitor of the postheparin 
clearing factor. ENGERBERG reported that the hyperlipemia might be 
caused by saturated, but not by unsaturated fatty acids and so satura-
ted fatty acids were hardly effected by lipoprotein lipase49). In this 
study, the lung fibrosis was produced in dogs by the injection of fibrin 
clots. Plasma lipolytic activity was reduced in fasted and force fed 
dogs in comparision with that of normal healthy dogs. From fasted
dogs, the lipolytic activity of dog lungs injected with clots was not 
different from that of normal healthy fasted dogs but from force fed 
dogs, the former was markedly reduced. This fact agreed with the re-
ports which the lipoprotein lipase might be liberated from the cell walls 
to the circulating blood by the action of heparin, and suggested the 
alteration of the pulmonary capillary bed led to the reduction of the 
production or to some change of the releasing mechanism of lipoprotein 
lipase from the capillary bed. The relationship between heparin and 
lipoprotein lipase has been discussed for many years. ANFINSEN et also' 
suggested that heparin was a part of the composition of lipoprotein li-
pase. Protamin and basophilic pigments which have the ability to com-
bine with heparin, inhibit the activity of lipoprotein lipase. SPITZER and 
SPITZER51) observed that the destruction of postheparin lipoprotein lipase 
occured by the hepatic heparinase and KORN52I reported that tissue lipo-
protein lipase was inactivated by heparinase of some bacteria, and su-
ggested that heparin was a part of an essential component of lipoprotein 
lipase. Dextran, phosphomoribudate and tungstate, and other sulphated 
polysaccharides of high molecular weight have heparinlike effect and 
all these substance.s are highly polar and carry a strong negative cha-
rge. Also in this study, the lipolytic activity of the perfusion fluids 
after the injection of dextran was markedly increased and lipolytic ac-
tivity of the lung tissue was markedly lowered from the other group 1 
and 2. HEINEMANNIB) demonstrated experimentally that free fatty acid 
was released from the rabbit lung when perfused with the exogeneous 
triglycerides and that rabbit lung had a lipoprotein lipase which was 
due to the pulmonary vasculature and not to that of the plasma. The 
free fatty acid from the hydrolysis of triglycerides was supplied to some 
tissues for the utilization as energy source. Furthermore, LOCHNER and 
NASSERI53) observed that free fatty acid concentration from the arterio-
venous blood of dogs was higher than that of simultaneously collected 
venous blood. In this experiment, the increase of free fatty acid was 
demonstrated in the perfusion fluid in the course of time, and the in-
creasing rate was lowered in the lung from clots injected dogs but ele-
vated mostly in the lung from dextran injected dogs. The explanation 
of the difference of the activity between dextran and heparin is diffi-
cult. The pulmonary surfactant has been studied by dextran induced 
lung edema by many investigators. Mammalian lung alveolus is lined 
by a thin film composing the air-liquid interface of alveolus, reduces 
the surface tension of the alveolus, and has the function of preserving 
the stability of fine air space during respiration. This specific surface 
active agents has been called pulmonary surfactant. PATTLE and THOMAS 
54) , and CLEMENTS55) suggested that this material was a lipid-protein 
complex and the predominant lipid was lecithin. From a clinical stand-
point, the changes in surface tension has been studied in hyaline mem-
brane disease 56),57),58) postperfusion syndrome 59) and oxygen intoxica-
tion60),61) KLAUS, C{ EMENTs and HAVEL62'found that the extracts of sur-
face active materials isolated from beef lungs contained 74% phospho-
lipids, 8% cholesterol, 10% triglyceride and 8% fatty acid and only the 
phospholipid fraction had a marked surface tension activity while cho-
lesterol, triglyceride and fatty acid had no activity. BROWN63) demon-
strated that palmitic acid increased in the fatty acid composition of leci-
thin. FINLEY, MORGAN and FIALKOW64I reported that distinct differences 
in the amount of lecithin between dog lung homogenate and lung wash 
was present. They also showed that the amount of phospholipid decr-
eased, and that lecithin in the phospholipid fraction contained increased 
amounts of esterified palmitate and that unsaturated fatty acid was 
lower following the absence of arachidonic acid in the lung after liga-
tion of the pulmonary artery. NAIMARK65),66) reported that the radioacti-
vity appeared in the lung tissue and 40% of the activity was in the 
phospholipid fraction one hour after the intravenous injection of palmi-
tate -1-C14 in dog and in experimental atelectasis, the activity was 
reduced. Furthermore, NAIMARK et a167' reported that about 50% of the 
total lipid activity appeared in phospholipid, about 25% in triglyceride, 
and most of the remaining activity in the free fatty acid fraction in 
the study of the incorporation with palmitate -1- C14 by rat lung in 
vitro. FELTS611 suggested some metabolic pathway in the alveolar cell 
concerned with circulating lipids that free fatty acid enters the cell 
directly from the plasma, from hydrolysis of plasma triglycerides by 
the effect of lipoprotein lipase or are synthesized within the cell from 
acetate. The Co-enzyme A derivatives of free fatty acid may be oxidized 
to C02 or esterificated to triglyceride and phospholipid depending on 
the availability of L-(-glycerol phosphate derived from glucose. KLAUS 
et al 69) and SAID71) reported that pulmonary surfactant might be synth-
esized in the alveolar cell mitochondria. On the otherhand, TOMBOROP-
OULOS71' discussed that the free fatty acid might be synthesized in the 
same subcellular fractions. In this study, the phospholipid content was 
markedly reduced in group 3. The amount of phosphatidyl choline was 
reduced in the force fed dogs of group 1 and 3. This change was mar-
ked in the dextran infused force fed dogs. These findings were obtained 
in the right (unperfused) and the left (perfused) lungs in the same 
way. From the gas liquid chromatographic analysis of phosphatidyl 
choline, the saturated fatty acid especially palmitic acid decreased and 
the unsaturated fatty acid increased in the dextran infused lung tissue. 
This fact may suggest the loss of surfactant . of the dextran infused 
lungs. Lipoprotein lipase from dextran infused postperfused lung tissue 
decreased markedly in comparison with control and clots injected groups. 
This fact may suggest the relationship between the free fatty acid 
production of lipoprotein lipase and synthesis of pulmonary surfactant 
and thus the lung also performs active metabolic functions,
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